跳至主要内容
临床试验/NCT02025894
NCT02025894已完成不适用

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

Institut de Cancérologie de la Loire27 个研究点 分布在 1 个国家目标入组 3,032 人开始时间: 2010年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,032
试验地点
27
主要终点
Thromboembolic complications:

研究概览

简要总结

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with a neoplastic solid tumour with an indication for insertion of a PCVC.

排除标准

  • Haematological neoplasm pathology, PCVC removal scheduled within 2 weeks of insertion,
  • Therapeutic doses of anticoagulants required at inclusion,
  • PCVC inserted by the femoral vein

结局指标

主要结局

Thromboembolic complications:

时间窗: one year

Locoregional or disseminated infectious complications:

时间窗: one year

次要结局

  • Medical and economic consequences of these complications(one year)

研究者

发起方
Institut de Cancérologie de la Loire
申办方类型
Other
责任方
Sponsor

研究点 (27)

Loading locations...

相似试验

Risk Factors for Thromboembolic and Infectious... | 临床试验